Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. (2022)

First Author: Dimiou S
Attributed to:  Delivering antibodies (molecular weight = 150 kDa) to the brain funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijpharm.2022.121658

PubMed Identifier: 35292396

Publication URI: http://europepmc.org/abstract/MED/35292396

Type: Journal Article/Review

Volume: 618

Parent Publication: International journal of pharmaceutics

ISSN: 0378-5173